ENDOXAN for Bone marrow conditioning regimen: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 23 adverse event reports in the FDA FAERS database where ENDOXAN was used for Bone marrow conditioning regimen.
Most Reported Side Effects for ENDOXAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 56 | 13.4% | 56 | 0 |
| No adverse event | 37 | 8.9% | 0 | 0 |
| Maternal exposure before pregnancy | 26 | 6.2% | 0 | 0 |
| Musculoskeletal disorder | 25 | 6.0% | 0 | 0 |
| Toxicity to various agents | 24 | 5.7% | 8 | 0 |
| Disease progression | 21 | 5.0% | 6 | 1 |
| Febrile neutropenia | 20 | 4.8% | 0 | 3 |
| Disease recurrence | 19 | 4.6% | 3 | 0 |
| Pneumonia | 15 | 3.6% | 3 | 1 |
| Acute graft versus host disease | 14 | 3.4% | 1 | 0 |
| Bone marrow failure | 11 | 2.6% | 3 | 3 |
| Drug ineffective | 11 | 2.6% | 6 | 1 |
| Exposure via father | 11 | 2.6% | 0 | 0 |
| Pyrexia | 11 | 2.6% | 2 | 9 |
| Breast cancer recurrent | 10 | 2.4% | 0 | 0 |
Other Indications for ENDOXAN
Breast cancer stage i (58)
Stem cell transplant (49)
Neoplasm malignant (37)
Lupus nephritis (24)
Chronic lymphocytic leukaemia (23)
Breast cancer (21)
Plasma cell myeloma (21)
B-cell lymphoma (14)
Diffuse large b-cell lymphoma (14)
Temporal arteritis (12)
Other Drugs Used for Bone marrow conditioning regimen
FLUDARABINE (6,080)
BUSULFAN (4,669)
CYCLOPHOSPHAMIDE (4,485)
MELPHALAN (2,368)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (1,884)
THIOTEPA (1,551)
ALEMTUZUMAB (1,122)
ETOPOSIDE (936)
CYTARABINE (833)
THYMOCYTE IMMUNE GLOBULIN NOS (742)